GCA
ARRY

Gideon Capital Advisors’s Array Biopharma Inc ARRY Stock Holding History

Gideon Capital Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-22,781
Closed -$1.05M – 429
2019
Q2 		$1.05M Buy
+22,781
New +$640K 0.36% 108

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Gideon Capital Advisors's ARRY Position: Q3 2019 in Review

Gideon Capital Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 22,781 shares — an estimated $1.05M sold.

Gideon Capital Advisors first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $1.05M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Gideon Capital Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 22,781 Array Biopharma Inc shares in Q3 2019, an estimated $1.05M.
  • Gideon Capital Advisors first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Gideon Capital Advisors's Array Biopharma Inc position peaked at $1.05M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Gideon Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.